Reducing Blood Pressure in Patients With High Cardiovascular Risk in the Safety-Net
a study on Heart Attack High Blood Pressure Stroke
Summary
- Eligibility
- for people ages 35 years and up (full criteria)
- Location
- at Downey, California and other locations
- Dates
- study startedcompletion around
Description
Summary
BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department of Health Services public healthcare system.
The goal of this clinical trial is to test if this team based program is better at helping people reduce their blood pressure than usual care for people with prior heart attack or stroke. The main questions it aims to answer are:
- Do people in the REACH BP program have lower blood pressure at 12 months compared to those getting usual care?
- Do people in the REACH BP program have better Life's Essential 8 scores and patient experience compared to those getting usual care?
Official Title
BP-REACH: Blood Pressure Disparities Reduction, Equity, and Access Among Safety Net Patients With Cardiovascular Health Risk
Details
Hypertension is the leading contributor to preventable death and a major risk factor for recurrent cardiovascular events. To enhance BP control after stroke or myocardial infarction (MI), multilevel interventions are needed that incorporate health system, patient, and community level factors.
BP-REACH aims to test the impact of an intervention on systolic blood pressure (SBP) for individuals with a history of stroke or MI in a randomized controlled trial in the Los Angeles Department of Health Services public healthcare system. The primary outcome will be change in systolic blood pressure (SBP) at 12 months.
Hypothesis: Patients randomized to the intervention will achieve >2.4 mm Hg greater reduction in SBP at 1 year versus those randomized to usual care.
The study population will include participants from the inpatient and outpatient settings in Los Angeles County Department of Health Services health centers. The participants will be randomized in a 1:1 fashion to usual care or intervention, stratified by site, language and cardiovascular event (myocardial infarction, stroke). Outcomes will be collected from all participants at Baseline, 3 month and 12 month timepoints. The primary outcome is SBP.
Participants randomized to the intervention arm will receive additional a home blood pressure monitor, monthly phone calls from a health coach, and medication initiation and titration by a clinical pharmacist. The pharmacist will follow Los Angeles County Department of Health Services expected practices, which align with the ACC/AHA guidelines for blood pressure control and AHA guidelines for Secondary Stroke Prevention.
Keywords
Myocardial Infarction, Hypertension, Stroke, self-management, Infarction, BP REACH Intervention
Eligibility
You can join if…
Open to people ages 35 years and up
- Patients of LA General Medical Center, Rancho Los Amigos, Olive Medical Center or Harbor-UCLA Medical Center with ischemic stroke, hemorrhagic stroke, or myocardial infarction
- English or Spanish speaking
- Systolic blood pressure (SBP) ≥ 130 mm Hg
Locations
- Rancho Los Amigos National Rehabilitation Center
accepting new patients
Downey California 90242 United States - Harbor UCLA Medical Center
not yet accepting patients
Torrance California 90502 United States - LA General Medical Center
accepting new patients
Los Angeles California 90033 United States - Olive View Medical Center
not yet accepting patients
Sylmar California 91342 United States
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of Southern California
- ID
- NCT05937685
- Study Type
- Interventional
- Participants
- Expecting 1000 study participants
- Last Updated
Please contact me about this study
We will not share your information with anyone other than the team in charge of this study, which might include an external sponsor. Submitting your contact information does not obligate you to participate in research.
Thank you!
The study team should get back to you in a few business days.